Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Sees Critical Path Opportunity To Address Follow-On Biologics

Apr 10 2006

• By The Pink Sheet

Related Content

Follow-Ons Off? FDA Shelves Near-Term Plans For Biologics Documents

Oct 10 2005

Drug Safety Stays At Top Of FDA’s Agenda With New Guidances In The Works

Mar 13 2006

FDA To Provide Updates On Critical Path Opportunities List Projects

Mar 20 2006

Amgen Trials For Manufacturing Changes Touted As Model For Bio-Generics

Feb 21 2005

FDA Generic Biologics Short-Term Plan Includes Immunogenicity Document

Mar 07 2005

Omnitrope Lawsuit Could Further Delay FDA “Follow-On” Biologics Guidance

Sep 19 2005

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window